Diadia
Our TechnologyResourcesAboutLoginBook a call

© 2026 Diadia. All rights reserved.

About UsOur TechnologyResearchResources
Privacy Policy
SupportBook a callLogin
Health Privacy Policy
InstagramFacebookLinkedInX (formerly Twitter)
Terms and Conditions
About UsOur TechnologyResearchResources
Privacy Policy
SupportBook a callLogin
Health Privacy Policy
InstagramFacebookLinkedInX (formerly Twitter)
Terms and Conditions

© 2026 Diadia. All rights reserved.

←Transparency Reports

endocrine · Mechanism Report

Does DHEA-S reflect adrenal androgen production and decline with age and chronic stress?

DHEA-S is a specific marker of adrenal androgen output that peaks in early adulthood and steadily declines with age, and it often falls in the setting of chronic psychosocial stress.

PlausibleJune 19, 202616 Sources

Reasoning Paths

Each route from condition to outcome carries a support score — the product of its edge weights. Select one to isolate it on the figure.

This is what AI claimed

DHEA-S reflects adrenal androgen production, and levels decline with age and chronic stress.

laying out figure…
6 of 7 paths supported
UnsupportedPlausibleSupported

How to read the figure

Evidence state

  • ●EstablishedStrong, replicated evidence.
  • ◐ModerateEvidence-informed; limited or moderate.
  • ◇PlausibleMechanistically coherent, not established.
  • ✕UnsupportedTested and not supported — link breaks.
  • ?MissingNo evidence either way — untested.

Node shapes

  • BiomarkerA measurable state — a lab value, hormone, or genetic factor.
  • ProcessA biological process, pathway, or mechanism step.
  • ConditionA condition, exposure, intervention, or symptom.
  • OutcomeThe endpoint the claim leads to.

Executive summary

The claim states that circulating DHEA-S primarily reports adrenal zona reticularis capacity and is biochemically stabilized by sulfation, making it a reliable indicator of adrenal androgen synthesis. Mechanistic evidence links age-related zona reticularis atrophy and changes in sulfotransferase activity to lifelong declines in DHEA-S, while chronic stress and HPA-axis shifts favor cortisol production over DHEA-S, commonly lowering its levels.

Verified conclusion

Dehydroepiandrosterone sulfate (DHEA-S) serves as a specialized biomarker for the functional capacity of the adrenal cortex. In humans, it is produced almost exclusively within the adrenal glands, reaching peak levels in early adulthood before beginning a steady, lifelong decline.

Physiological role and production

DHEA-S is a direct indicator of adrenal androgen synthesis. Unlike its precursor DHEA, DHEA-S has a long half-life and stable blood concentrations, making it a reliable clinical marker.

  • Adrenal specificity: In adult women, the adrenal glands produce nearly 100% of circulating DHEA-S. This occurs specifically in the zona reticularis (ZR) layer of the adrenal cortex.
  • Molecular mechanisms: The production depends on a unique enzymatic environment in the ZR, characterized by high levels of steroid sulfotransferase (SULT2A1) and cytochrome b5, alongside low levels of 3β-hydroxysteroid dehydrogenase. This profile facilitates the conversion of DHEA into its sulfate form while preventing its conversion into other steroids like cortisol or testosterone.

Age-related decline (Adrenopause)

The decline of DHEA-S with age is one of the most consistent phenomena in endocrinology, often termed "adrenopause."

  • Life course trajectory: Levels peak between ages 20 and 30 and decline by approximately 2% per year thereafter. By age 70–80, levels typically drop to just 10–20% of their peak values.
  • Menopausal nuances: For a 50-year-old female, research such as the SWAN study indicates that while the overall trajectory is downward, the perimenopausal transition can cause temporary fluctuations where DHEA-S levels may briefly rise or stabilize before resuming their decline.
  • Functional impact: Lower DHEA-S levels in older adults are associated with reduced muscle strength, slower gait speed, and increased cardiovascular risk.

Impact of chronic stress

Chronic stress influences DHEA-S through the hypothalamic-pituitary-adrenal (HPA) axis, though the response varies by the nature and duration of the stressor.

  • Adrenal exhaustion: In states of chronic psychosocial strain and burnout, DHEA-S levels frequently decline. One study observed that younger individuals with burnout had DHEA-S levels approximately 25% lower than healthy controls.
  • Cortisol/DHEA-S ratio: Chronic stress often shifts adrenal production toward cortisol at the expense of DHEA-S, leading to a higher cortisol-to-DHEA-S ratio. This shift is a key marker of "allostatic load," or the wear and tear on the body from chronic stress.
  • Contextual variation: While psychosocial stress typically lowers DHEA-S, acute or different types of physiological stress may occasionally result in elevated levels, depending on the individual's HPA axis resilience.

Bottom line

The claim is strongly supported by scientific evidence: DHEA-S is a specific marker of adrenal androgen production that declines significantly with age and frequently drops in response to chronic psychosocial stress and burnout. For a 50-year-old female, DHEA-S levels likely reflect the cumulative effects of aging and current stress levels on adrenal function.

References

  1. Regulation of the adrenal androgen biosynthesis — pmc.ncbi.nlm.nih.gov ↗
  2. Adrenal changes associated with adrenarche — pmc.ncbi.nlm.nih.gov ↗
  3. Liquid chromatography-tandem mass spectrometry analysis of human adrenal vein 19-carbon steroids before and after ACTH stimulation. — pmc.ncbi.nlm.nih.gov ↗
  4. The zona reticularis is the site of biosynthesis of dehydroepiandrosterone and dehydroepiandrosterone sulfate in the adult human adrenal cortex resulting from its low expression of 3 beta-hydroxysteroid dehydrogenase. — academic.oup.com ↗
  5. Adrenal Aging: Region-Specific Vulnerability and Proteostatic Decline - Mechanisms, Biomarkers, and Translational Opportunities. — aginganddisease.org ↗
  6. A review of age-related dehydroepiandrosterone decline and its association with well-known geriatric syndromes: is treatment beneficial? — pmc.ncbi.nlm.nih.gov ↗
  7. Dehydroepiandrosterone (DHEA), DHEA sulfate, and aging: contribution of the DHEAge Study to a sociobiomedical issue. — pmc.ncbi.nlm.nih.gov ↗
  8. The Utilization of Dehydroepiandrosterone as a Sexual Hormone Precursor in Premenopausal and Postmenopausal Women: An Overview — pmc.ncbi.nlm.nih.gov ↗
  9. 11-Oxygenated C19 Steroids Do Not Decline With Age in Women. — pmc.ncbi.nlm.nih.gov ↗
  10. Adrenal androgens and the menopausal transition. — pmc.ncbi.nlm.nih.gov ↗
  11. DHEA as a Biomarker of Stress: A Systematic Review and Meta-Analysis — frontiersin.org ↗
  12. Perceived Stress at Work Is Associated with Lower Levels of DHEA-S — pmc.ncbi.nlm.nih.gov ↗
  13. Low Levels of Dehydroepiandrosterone Sulfate in Younger Burnout Patients — pmc.ncbi.nlm.nih.gov ↗
  14. Measuring stress: a review of the current cortisol and dehydroepiandrosterone (DHEA) measurement techniques and considerations for the future of mental health monitoring — tandfonline.com ↗
  15. Estrogen sulfotransferase and sulfatase in steroid homeostasis, metabolic disease, and cancer — pmc.ncbi.nlm.nih.gov ↗
  16. DHEA-S levels and cardiovascular disease mortality in postmenopausal women: results from the National Institutes of Health--National Heart, Lung, and Blood Institute (NHLBI)-sponsored Women's Ischemia Syndrome Evaluation (WISE). — pmc.ncbi.nlm.nih.gov ↗

See a full patient report verified like this

Book a walkthrough

Related Claims

Plausible8 sourcesCan obstructive sleep apnea lower testosterone in men?→Plausible5 sourcesDoes a non-elevated LH with low testosterone suggest secondary hypogonadism?→